Google Chrome
Safari
Firefox
Edge
Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
Scientific Article
/ Jan 01, 2014
Experimental design for the optimization and robustness testing of a liquid chromatography tandem mass spectrometry method for the trace analysis of the potentially genotoxic 1,3-diisopropylurea
Read more
Scientific Article
/ Jan 01, 2013
Environmental and economic analysis for selection and engineering sustainable API degenotoxification processes
Read more
Scientific Article